Homepage
Author:
Zhongshan Kangfang Biological Medicine Co., LTD
Posted Date:
January 24, 2026
Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis
Zhongshan Kangfang Biological Medicine Co., LTD
January 24, 2026